Patent for Method for Immunomodulation of using Aza-podophyllotoxin derivatives
By Ferraiuoli LLC
On July 16, 2024, the United States Patent and Trademark Office published patent number 12036270, titled Method for Immunomodulation of using Aza-podophyllotoxin derivatives, prosecuted by Ferraiuoli for its client SISTEMA UNIVERSITARIO ANA G. MÉNDEZ.
Aza-podophyllotoxin derivatives are modified versions of a natural compound found in the Mayapple plant. These derivatives have shown promise in cancer treatment due to their ability to kill cancer cells.
Certain aza-podophyllotoxin derivatives can stimulate the production of immune-related proteins like G-CSF and IL-6. These proteins play crucial roles in immune function.
If successful, this research could lead to:
New immunotherapies: Developing treatments that boost the immune system to fight diseases like cancer.
Improved vaccine efficacy: Enhancing the effectiveness of vaccines by stimulating a stronger immune response.
Treatment for autoimmune diseases: Potentially regulating an overactive immune system in autoimmune conditions.